Results
1 -
10 of
18Characterization of an engineered human purine nucleoside phosphorylase fused to an anti-her2/neu single chain Fv for use in ADEPT, Journal of Experimental & Clinical Cancer Research Molecular and biochemical elucidation of a cellular phenotype characterized by adenine analogue resistance in the presence of high levels of adenine phosphoribosyltransferase activity, Biochemical Genetics Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced breast cancer, Cancer Chemotherapy and Pharmacology Targeted enzyme prodrug therapy for metastatic prostate cancer u2013 a comparative study of L-methioninase, purine nucleoside phosphorylase, and cytosine deaminase, Journal of Biomedical Science Characterization of new G protein-coupled adenine receptors in mouse and hamster, Purinergic Signalling Molecular and biochemical elucidation of a cellular phenotype characterized by adenine analogue resistance in the presence of high levels of adenine phosphoribosyltransferase activity, Biochemical Genetics Prodrug converting enzyme gene delivery by L. monocytogenes, BMC Cancer In vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase, Cancer Chemotherapy and Pharmacology [3H]Adenine is a suitable radioligand for the labeling of G protein-coupled adenine receptors but shows high affinity to bacterial contaminations in buffer solutions, Purinergic Signalling Delivery of high levels of anti-proliferative nucleoside triphosphates to CYP3A-expressing cells as a potential treatment for hepatocellular carcinoma, Cancer Chemotherapy and Pharmacology